mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.6 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |